A distinct serum metabolic signature outperforms C-reactive protein as a non-invasive marker for monitoring disease activity in Inflammatory Bowel Disease
Year: 2025
Type: preprint
Topic: Metabolomics and Mass Spectrometry Studies
Authors and affiliations:
raw_author_name: Lina Welz
raw_affiliation_strings: Department of Internal Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
raw_author_name: Björn-Hergen Laabs
raw_affiliation_strings: Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany
Institute of Medical Biometry and Statistics, University of Lübeck, Lübeck, Germany
raw_author_name: Danielle Harris
raw_affiliation_strings: Nova Scotia Government, Department of Health and Wellness, Halifax, Nova Scotia, Canada
raw_author_name: Sven Schuchardt
raw_affiliation_strings: Fraunhofer-Institut für Toxikologie und Experimentelle Medizin, Hannover
raw_author_name: Florian Tran
raw_affiliation_strings: Department of Internal Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
raw_author_name: Silvio Waschina
raw_affiliation_strings: Institute for Human Nutrition and Food Science, Division of Nutriinformatics, Christian-Albrechts-University of Kiel, Kiel, Germany
raw_author_name: Norbert Frey
raw_affiliation_strings: Department of Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany
German Centre for Cardiovascular Research (DZHK), Partner site Hamburg, Kiel, Lübeck, Germany
raw_author_name: Andre Franke
raw_affiliation_strings: Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
raw_author_name: Bram Verstockt
raw_affiliation_strings: Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium
Department of Gastroenterology and Hepatology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
raw_author_name: Séverine Vermeire
raw_affiliation_strings: Department of Gastroenterology and Hepatology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
raw_author_name: Philip Rosenstiel
raw_affiliation_strings: Department of Internal Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
raw_author_name: Stefan Schreiber
raw_affiliation_strings: Department of Internal Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
raw_author_name: Konrad Aden
raw_affiliation_strings: Department of Internal Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany